Estimated out-of-pocket costs for cancer-directed and supportive care medications for older adults with advanced pancreatic cancer

• DOI: 10.1016/j.jgo.2022.02.003
• Publication Date: 2022-02-12T12:31:54Z
• Authors: Nidhi Desai; Robert J. Besaw; Ramy Sedhom; Syed M. Qasim Hus...; Anne H. Blaes; Stacie B. Dusetzina; Arjun Gupta
• Keywords: Pancreatic Neoplasms; 03 medical and health sciences; 0302 clinical medicine; Humans; Health Care Costs; Health Expenditures; Aged

Over 62,000 U.S. adults will be diagnosed with pancreatic cancer in 2022 [1]. The median age at diagnosis is 71 years, and by 2030, 70% of occur older [2,3]. Almost 90% patients report least one moderate-to-severe symptom (score ≥4 on a 0–10 self-reported scale) [4]. These symptoms frequently cluster together, are persistent through the course illness Patients may experience due to itself (e.g., pain) or its treatment chemotherapy-induced peripheral neuropathy) [5].